{
    "clinical_study": {
        "@rank": "16900", 
        "brief_summary": {
            "textblock": "This study will test whether the G17DT Immunogen, when administered in combination with\n      chemotherapy, is an effective and safe treatment for gastric cancer."
        }, 
        "brief_title": "Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer", 
        "condition": [
            "Stomach Neoplasms", 
            "Esophageal Neoplasms"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Esophageal Neoplasms", 
                "Stomach Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Clinical diagnosis with gastric or gastroesophageal cancer\n\n          -  Karnofsky performance status score of at least 70\n\n          -  Life expectancy of at least 3 months\n\n        Exclusion criteria:\n\n          -  Prior treatment with chemotherapy or anticancer immunotherapy\n\n          -  Bone marrow transplant within past year\n\n          -  Chronic use of corticosteroids, except for inhaled corticosteroids used for asthma or\n             chronic obstructive pulmonary disease\n\n          -  Central nervous system metastases\n\n          -  Immunodeficiency\n\n          -  Hypercalcemia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "July 31, 2002", 
        "id_info": {
            "nct_id": "NCT00042510", 
            "org_study_id": "GC4"
        }, 
        "intervention": {
            "intervention_name": "G17DT Immunogen", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Gastrins"
        }, 
        "keyword": [
            "Gastroesophageal cancer", 
            "Gastric cancer"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00042510"
        }, 
        "source": "Aphton", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Aphton", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2002"
    }, 
    "geocoordinates": {}
}